LITYNDA Trademark

Trademark Overview


On Monday, May 23, 2016, a trademark application was filed for LITYNDA with the United States Patent and Trademark Office. The USPTO has given the LITYNDA trademark a serial number of 79190853. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, June 13, 2022. This trademark is owned by Novartis AG. The LITYNDA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the preven...
litynda

General Information


Serial Number79190853
Word MarkLITYNDA
Filing DateMonday, May 23, 2016
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, June 13, 2022
Registration Number5153313
Registration DateTuesday, March 7, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 20, 2016

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateMonday, June 13, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Sunday, January 8, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sunday, January 8, 2023DEATH OF INTERNATIONAL REGISTRATION
Monday, March 7, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Saturday, July 8, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, June 20, 2017FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, June 20, 2017FINAL DISPOSITION PROCESSED
Wednesday, June 7, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 7, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, December 20, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 20, 2016PUBLISHED FOR OPPOSITION
Wednesday, November 30, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 7, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, November 5, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 4, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 4, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 26, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 26, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, October 2, 2016REFUSAL PROCESSED BY IB
Thursday, September 15, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, September 15, 2016REFUSAL PROCESSED BY MPU
Wednesday, September 14, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, September 13, 2016NON-FINAL ACTION WRITTEN
Saturday, September 10, 2016APPLICATION FILING RECEIPT MAILED
Thursday, September 8, 2016ASSIGNED TO EXAMINER
Tuesday, September 6, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, August 26, 2016LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, August 25, 2016SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB